Lyons Gary A - May 15, 2025 Form 4 Insider Report for Travere Therapeutics, Inc. (TVTX)

Role
Director
Signature
/s/ Elizabeth E. Reed, Attorney-in-Fact
Stock symbol
TVTX
Transactions as of
May 15, 2025
Transactions value $
$0
Form type
4
Date filed
5/16/2025, 07:00 PM
Previous filing
Oct 4, 2024
Next filing
May 22, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
LYONS GARY A Director C/O TRAVERE THERAPEUTICS, INC., 3611 VALLEY CENTRE DR., SUITE 300, SAN DIEGO /s/ Elizabeth E. Reed, Attorney-in-Fact 2025-05-16 0001123343

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TVTX Common Stock Award $0 +6.5K +12.75% $0.00 57.5K May 15, 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TVTX Stock option (right to buy) Award $0 +19.5K $0.00 19.5K May 15, 2025 Common Stock 19.5K $21.15 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program.
F2 The equity award vests over a one year period.